Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Mar;23(3):665–669. doi: 10.1128/iai.23.3.665-669.1979

Inhibition of in vitro proliferative responses of human lymphocytes by rimantadine hydrochloride.

W C Koff, D L Peavy, V Knight
PMCID: PMC414216  PMID: 457254

Abstract

Rimantadine hydrochloride (alpha-methyl-1-adamantanemethylamine hydrochloride) inhibits the in vitro proliferative response of human peripheral blood lymphocytes to mitogenic and antigenic stimulation. Addition of drug (25 micrograms/ml) at the initiation of 5-day cultures suppressed the responses to phytohemagglutinin, pokeweed mitogen, and concanavalin A by 25, 65, and 90%, respectively. Similarly, responses to streptokinase-streptodornase, tetanus toxoid, and A2/Aichi influenza vaccine were significantly inhibited at concentrations as low as 10 micrograms of rimantadine per ml. Viability studies on 5-day cultures using trypan blue exclusion showed no significant difference between drug-treated and untreated controls. Furthermore, addition of drug on day 3 of 8-day cultures, at a time when the majority of cells had undergone blastogenesis, greatly suppressed the responses to these mitogens. These studies suggest that, in addition to its antiviral action, rimantadine interferes with the generation of cellular immune responses.

Full text

PDF
665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bleidner W. E., Harmon J. B., Hewes W. E., Lynes T. E., Hermann E. C. Absorption, distribution and excretion of amantadine hydrochloride. J Pharmacol Exp Ther. 1965 Dec;150(3):484–490. [PubMed] [Google Scholar]
  2. Ciak J., Hahn F. E. Chloroquine: mode of action. Science. 1966 Jan 21;151(3708):347–349. doi: 10.1126/science.151.3708.347. [DOI] [PubMed] [Google Scholar]
  3. DAVIES W. L., GRUNERT R. R., HAFF R. F., MCGAHEN J. W., NEUMAYER E. M., PAULSHOCK M., WATTS J. C., WOOD T. R., HERMANN E. C., HOFFMANN C. E. ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). Science. 1964 May 15;144(3620):862–863. doi: 10.1126/science.144.3620.862. [DOI] [PubMed] [Google Scholar]
  4. Effros R. B., Doherty P. C., Gerhard W., Bennink J. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med. 1977 Mar 1;145(3):557–568. doi: 10.1084/jem.145.3.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Glasgow L. A. Cellular immunity in host resistance to viral infections. Arch Intern Med. 1970 Jul;126(1):125–134. [PubMed] [Google Scholar]
  6. Greenberg S. B., Criswell B. S., Couch R. B. Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method. J Immunol. 1975 Aug;115(2):601–603. [PubMed] [Google Scholar]
  7. HURVITZ D., HIRSCHHORN K. SUPPRESSION OF IN VITRO LYMPHOCYTE RESPONSES BY CHLOROQUINE. N Engl J Med. 1965 Jul 1;273:23–26. doi: 10.1056/NEJM196507012730105. [DOI] [PubMed] [Google Scholar]
  8. Hobson D., Curry R. L., Beare A. S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972 Dec;70(4):767–777. doi: 10.1017/s0022172400022610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hoffmann C. E., Neumayer E. M., Haff R. F., Goldsby R. A. Mode of Action of the Antiviral Activity of Amantadine in Tissue Culture. J Bacteriol. 1965 Sep;90(3):623–628. doi: 10.1128/jb.90.3.623-628.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kato N., Eggers H. J. Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride. Virology. 1969 Apr;37(4):632–641. doi: 10.1016/0042-6822(69)90281-5. [DOI] [PubMed] [Google Scholar]
  11. Lucas S. J., Barry D. W., Kind P. Antibody production and protection against influenza virus in immunodeficient mice. Infect Immun. 1978 Apr;20(1):115–119. doi: 10.1128/iai.20.1.115-119.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rabinovich S., Baldini J. T., Bannister R. Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak. Am J Med Sci. 1969 May;257(5):328–335. doi: 10.1097/00000441-196905000-00005. [DOI] [PubMed] [Google Scholar]
  13. Rawls W. E., Melnick J. L., Olson G. B., Dent P. B., Good R. A. Effect of amantadine hydrochloride on the response of human lymphocytes to phytohemagglutinin. Science. 1967 Oct 27;158(3800):506–507. doi: 10.1126/science.158.3800.506. [DOI] [PubMed] [Google Scholar]
  14. Ruben F. L., Jackson G. G., Gotoff S. P. Humoral and cellular response in humans after immunization with influenza vaccine. Infect Immun. 1973 Apr;7(4):594–596. doi: 10.1128/iai.7.4.594-596.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stephen E. L., Dominik J. W., Moe J. B., Spertzel R. O., Walker J. S. Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes. Antimicrob Agents Chemother. 1975 Aug;8(2):154–158. doi: 10.1128/aac.8.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sullivan J. L., Mayner R. E., Barry D. W., Ennis F. A. Influenza virus infection in nude mice. J Infect Dis. 1976 Jan;133(1):91–94. doi: 10.1093/infdis/133.1.91. [DOI] [PubMed] [Google Scholar]
  17. Suzuki F., Oya J., Ishida N. Effect of antilymphocyte serum on influenza virus infection in mice. Proc Soc Exp Biol Med. 1974 May;146(1):78–84. doi: 10.3181/00379727-146-38047. [DOI] [PubMed] [Google Scholar]
  18. Walker J. S., Stephen E. L., Spertzel R. O. Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice. J Infect Dis. 1976 Jun;133 (Suppl):A140–A144. doi: 10.1093/infdis/133.supplement_2.a140. [DOI] [PubMed] [Google Scholar]
  19. Wallbank A. M. Alpha-methyl-1-adamantane-methylamine hydrochloride: inhibition of Rous and Esh sarcoma viruses in cell culture. Proc Soc Exp Biol Med. 1969 Jul;131(3):1025–1027. doi: 10.3181/00379727-131-34032. [DOI] [PubMed] [Google Scholar]
  20. Wheelock E. F., Toy S. T. Participation of lymphocytes in viral infections. Adv Immunol. 1973;16:123–184. doi: 10.1016/s0065-2776(08)60297-7. [DOI] [PubMed] [Google Scholar]
  21. Wingfield W. L., Pollack D., Grunert R. R. Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man. N Engl J Med. 1969 Sep 11;281(11):579–584. doi: 10.1056/NEJM196909112811102. [DOI] [PubMed] [Google Scholar]
  22. Wyde P. R., Couch R. B., Mackler B. F., Cate T. R., Levy B. M. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun. 1977 Jan;15(1):221–229. doi: 10.1128/iai.15.1.221-229.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. YOFFEY J. M., WINTER G. C., OSMOND D. G., MEEK E. S. MORPHOLOGICAL STUDIES IN THE CULTURE OF HUMAN LEUCOCYTES WITH PHYTOHAEMAGGLUTININ. Br J Haematol. 1965 Jul;11:488–497. doi: 10.1111/j.1365-2141.1965.tb06613.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES